← FDA Drug Approvals (Drugs@FDA)
KALETRA
NDA · New Drug Application · Sponsor: ABBVIE · Approved 2005-10-28
Drug application
- FDA Application #
NDA021906- Application type
- New Drug Application
- Brand name
- KALETRA
- Generic name
- LOPINAVIR AND RITONAVIR
- Active ingredients
- LOPINAVIR; RITONAVIR
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ABBVIE
- Manufacturer
- AbbVie Inc.
- First approval
- 2005-10-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown